Radioimmunoassay of parathyroid hormone (PTH) in human serum was carried out using guinea pig antibody against bovine parathyroid hormone and 125I labeled highly purified bovine PTH employing dextran-coated charcoal to separate the bound and free fraction. With the use of this method, PTH was detected in the serum of about 85% of 118 normal male and female subjects of various ages. PTH in serum was definitely elevated in primary and secondary hyperparathyroidism and pseudohypoparathyroidism but was undetectable or low in idiopathic and postoperative hypoparathyroidism. In 11 patients with postmenopausal osteoporosis with compression fracture, serum PTH was significantly higher than in age-matched controls. Serum PTH increased along with the progress in the severity of vertebral bone change in X-ray picture.
Since the method of radioimmunoassay of parathyroid hormone (PTH) became available, measurement of PTH in human blood was carried out in various diseases, despite the limitation of the method on account of its dependence on the cross-immunity between human and either bovine or porcine PTH (Berson et al., 1963; Reiss and Canterbury, 1968; Schopman et al., 1970 and Arnaud et al., 1971) . However, PTH in serum of patients with postmenopausal osteoporosis, a major age-dependent metabolic bone disease after middle age, has not been studied in detail. In the present study, the method of radioimmunoassay of PTH was extended to patients with postmenopausal osteoporosis, in an attempt to elucidate the role of PTH in the development of osteoporosis. Results Figure 1 shows the dilution curves for bovine PTH and standard human serum PTH. Despite some discrepancy between these 2 curves at higher concentration, partial superimposition makes it possible to calculate human serum PTH in terms of ng/ml bovine PTH. Table 1 summarizes the immunoreactive PTH level in normal human serum. PTH was undetectable or below 0.15ng/ml in 9 of 55 males and 9 of 63 females. There appears to be a tendency of decrease of PTH in serum with advancing age in both males and females, though the variation was rather wide in each age group. Fig.2 . Serum parathyroid hormone expressed in bovine parathyroid hormone equivalent (ng/ml) in osteoporotics with compression fracture and age-matched controls without osteoporosis.
parathyroidism. Serum PTH was definitely elevated in primary and secondary hyperparathyroidism and pseudohypoparathyroidism but was undetectable in postoperative and idiopathic hypoparathyroidism. Figure 2 shows the serum PTH in 11 paitents with postmenopausal osteoporosis with compression fracture. Osteoporotics as a group had significantly higher serum PTH level than normal subjects of corresponding age, but 4 of the 11 of these patients had serum PTH level overlapping the normal range and 7 had definitely elevated levels. methods but serum from normal subjects was frequently undetectable except in the studies of Reiss et al.(1968) . Arnaud et al.(1971) were able to detect PTH in 95% of normal subjects, using an antibody to porcine PTH, which is not yet widely available. Since it is mandatory to detect PTH in most of the normal subjects to study the change of serum PTH according to age and compare it with that in osteoporotics, we have attempted to produce antibodies against bovine PTH in guinea pig with high titer and good binding capacity to human PTH. The method of Schopman et al.(1970) was essentially followed because of its apparent simplicity and high sensitivity with utmost precautions in setting up damage control. This method proved rather satisfactory in our hands in precision and reproducibility, and was able to detect as little as 0.15ng/ml bovine PTH equivalent.
Definitely elevated PTH levels in serum in primary and secondary hyperparathyroidism as well as pseudohypoparathyroidism and undetectable level of PTH in postoperative and idiopathic hypoparathyroidism might indicate the usefulness of this method of radioimmunoassay of PTH in the diagnosis of diseases of the parathyroids.
Changes of serum PTH according to age and sex have not been sufficiently documented. With the use of the present method, which is capable of detecting PTH in about 85% of normal subjects, no definite sex difference appeared to be present but a tendency of Serum PTH and Lumbar Score Fig.3 . Correlation between serum parathyroid hormone expressed in bovine parathyroid hormone equivalent and Lumbar Score or the ratio between the middle and anterior height of the third lumbar vertebra expressing the degree of deformity. Endocrinol. Japon. December 1972 decline with advancing age was noted in serum PTH.
In postmenopausal osteoporosis with compression fracture serum PTH appeared to be definitely higher than in normal subjects of corresponding age without evident osteoporosis. Though the accurate assessment of the severity of osteoporosis in X-ray film is notoriously difficult, a progressive increase in the severity of osteoporosis is suggested in view of the significant negative correlation between lumbar score, an index of the progress of vertebral deforming due to osteoporosis and serum PTH level. Serum calcium and phosphorus stayed within normal range in all these patients with osteoporosis. Serum alkaline phosphatase was slightly elevated in 2 of 11 patients with compression fracture but normal in all others. No radiographic evidence suggesting osteomalacia or hyperparathyroidism was noted in any of these cases. Although no bone biopsy was carried out, it is most likely that these patients had primary postmenopausal osteoporosis and no concurrent osteomalacia or osteisis Essential role of PTH in the development of osteoporosis was frequently suggested, since the increase of bone resorption was found to be predominant in osteoporosis. Parathyroidectomy prevented the development of experimental osteoporosis induced by low calcium diet and by immobilization (Burkhardt & Jowsey, 1967; Jowsey & Raisz, 1964) . Arnaud et al.(1972) found increased PTH level in about 15% of their patients with postmenopausal osteoporosis and explained it with normocalcemic hyperparathyroidism occurring in a limited number of patients with osteoporosis. Development of postmenopausal osteoporosis was explained by the loss of protective effect of estrogen on the action of parathyroid hormone on bone (Nordin, 1971; Hossain et al., 1970) through demonstration of thinner metacarpal cortical thickness in hyperparathyroid patients compared to hypoparathyroid patients after the menopause but not before menopause. Pak et al.(1969) treated patients with osteoporosis with intravenous calcium infusion and obtained positive calcium balance, explaining the effect with suppression of parathyroid hormone secretion or stimulation of calcitonin secretion.
Rise of serum parathyroid hormone in patients with osteoporosis is apparently not a physiological age-dependent process, since a general tendency of decline in serum PTH is noted in subjects without evident osteoporosis. It is therefore tempting to suggest that osteoporosis is not a consequence of natural aging of the skeletal system but represents a limited group of patients with disturbance of calcium metabolism, with secondary rise of serum PTH. Decrease of calcium absorption from the intestine in patients with osteoporosis is of interest, in view of the possible significance as a trigger for such sequence of event (Cannigia et al., 1963; Bullamore et al., 1970) .
